Matches in Wikidata for { <http://www.wikidata.org/entity/Q72685932> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q72685932 description "article scientifique publié en 1993" @default.
- Q72685932 description "artículu científicu espublizáu en payares de 1993" @default.
- Q72685932 description "im November 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72685932 description "scientific article published on 01 November 1993" @default.
- Q72685932 description "wetenschappelijk artikel" @default.
- Q72685932 description "наукова стаття, опублікована в листопаді 1993" @default.
- Q72685932 name "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 name "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 type Item @default.
- Q72685932 label "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 label "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 prefLabel "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 prefLabel "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 P1433 Q72685932-1779019A-1C44-41D5-958B-EC104B5230AE @default.
- Q72685932 P1476 Q72685932-464E2201-D9DF-4252-8642-EEC60FBE1074 @default.
- Q72685932 P2093 Q72685932-12116BA5-CA5B-4624-841C-E89DB10DFF8D @default.
- Q72685932 P2093 Q72685932-AF08C524-1134-4996-8819-962D242D477B @default.
- Q72685932 P304 Q72685932-C9C53FCE-E869-494F-9CAA-5ECCC916B042 @default.
- Q72685932 P31 Q72685932-17dd7229-43d6-4453-9b06-2c57b6a421f7 @default.
- Q72685932 P31 Q72685932-FC0C2899-C6D7-4A60-8DC7-9C3C103E331C @default.
- Q72685932 P433 Q72685932-193DC3B2-FFED-4567-AA51-CA9E2711CEE2 @default.
- Q72685932 P478 Q72685932-5516F65E-9796-447E-8E43-B34E6861B268 @default.
- Q72685932 P577 Q72685932-67F1EA87-0A38-44EA-980C-56273C11F183 @default.
- Q72685932 P698 Q72685932-A4E875AD-F884-463D-AC1E-C15A45920B1B @default.
- Q72685932 P921 Q72685932-4B601A10-E240-48C4-AF87-DC26DC29ED67 @default.
- Q72685932 P698 8272787 @default.
- Q72685932 P1433 Q27713404 @default.
- Q72685932 P1476 "[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]" @default.
- Q72685932 P2093 "Tsakiris DA" @default.
- Q72685932 P2093 "de Moerloose P" @default.
- Q72685932 P304 "2175-2182" @default.
- Q72685932 P31 Q13442814 @default.
- Q72685932 P31 Q7318358 @default.
- Q72685932 P433 "46" @default.
- Q72685932 P478 "123" @default.
- Q72685932 P577 "1993-11-01T00:00:00Z" @default.
- Q72685932 P698 "8272787" @default.
- Q72685932 P921 Q582207 @default.